Loading clinical trials...
Loading clinical trials...
Phase II Trial Evaluating the Efficacy and Safety of Romiplostim (Nplate) Treatment of Chemotherapy Induced Thrombocytopenia in Patients With Multiple Myeloma
Conditions
Interventions
romiplostim
Locations
1
United States
NYU Cancer Institute
New York, New York, United States
Start Date
January 1, 2013
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
October 15, 2018
NCT04973605
NCT06138275
NCT05862012
NCT07391657
NCT06285318
NCT07284758
Lead Sponsor
NYU Langone Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions